Michael Kranz

Michael Kranz has a diverse work experience in various industries. Michael is currently the Head of Business Development at TG Therapeutics, Inc., a position they have held since 2021. Prior to this, they worked as a Portfolio Manager - Biotech/Pharma Investor at Forest Glen Capital from 2020 to 2021. In 2018, they had a summer role as an MBA Summer in the Pharma Group at Goldman Sachs. From 2009 to 2017, they served as a Senior Biotech Investment Analyst at Opus Point Partners. Michael began their career in 1993 as a member of the Children's Choir at the Metropolitan Opera, a role they held until 1996.

Michael Kranz has a Master of Business Administration (MBA) degree from The Wharton School. Michael also completed the Business Bridge Program at The Tuck School of Business at Dartmouth, where they received a Certificate of Completion. In addition, Michael attended Hamilton College and Horace Mann School, but their degree and field of study are not specified for these institutions.